Brazil Self-Monitoring Blood Glucose Devices Market Size

Brazil Self-Monitoring Blood Glucose Devices Market Analysis

The Brazil Self-Monitoring Blood Glucose Devices Market size is estimated at USD 359 million in 2024, and is expected to reach USD 441 million by 2029, growing at a CAGR of 4.60% during the forecast period (2024-2029).

Continued elevation in blood glucose levels in diabetes patients can contribute to progressive complications such as renal, nerve, and ocular damage. The measurement of blood glucose helps in determining the effectiveness of blood glucose metabolism and guides in achieving optimal glucose control within the body. Over time, the readings provide the patient and their health professionals with the information required to determine the best management strategy for diabetes. Appropriate and timely monitoring of blood glucose allows the successful management of out-of-range blood glucose levels, minimizing diabetic-related health complications.

In Brazil, the public health system (Sistema Nico de Sade; SUS) has been progressively increasing the assistance available for individuals with diabetes. The Ministry of Health established a list of medications and supplies provided by the Brazilian Health System (SUS) to patients suffering from diabetes. However, their supply is usually not sufficient or recommended for optimal patient management across cities. The high prevalence of diabetes is associated with a significant economic burden.

Technological advancements in blood glucose meters, including cellular-connected devices that automatically upload SMBG data to secure cloud-based databases, allow for improved sharing and monitoring of SMBG data. Real-time monitoring of SMBG data presents opportunities to provide timely support to patients who are responsive to abnormal SMBG recordings. Such advantages can provide patients with poorly controlled T2D with the additional support needed to improve critical outcomes, thereby enhancing the market's prospects in the years to come.